Cas9 Stable Cell Line - ATDC5

The Cas9 Stable Cell Line - ATDC5 is a genetically engineered mouse chondrocyte progenitor cell line designed for precise genome editing applications. Derived from the original ATDC5 cell line isolated from mouse teratomas, its variants stably express the Streptococcus pyogenes Cas9 endonuclease under constitutive promoter control, eliminating the need for repeated transfection of CRISPR components. These cells retain their inherent chondrocyte differentiation capacity even under insulin-transferrin-selenium (ITS) stimulation, making them ideal for skeletal development research.

The Cas9 Stable Cell Line - ATDC5 is a powerful tool for musculoskeletal research, particularly suitable for constructing models of chondrocyte development, osteoarthritis, and bone metabolism. Researchers use this cell line for high-throughput CRISPR screening to identify genes regulating chondrocyte differentiation, matrix mineralization, and inflammatory pathways associated with joint degeneration. Its applications extend to drug development, where targeted gene knockout can validate therapeutic targets for anti-osteoporosis or chondroprotective compounds. This cell line also facilitates mechanistic studies of extracellular matrix proteins such as collagen II and proteoglycans through precise gene editing. Furthermore, it supports tissue engineering research, allowing for genetic manipulation of signaling pathways (e.g., BMP, Wnt) to optimize cartilage tissue construction. The model''s compatibility with 3D culture systems further promotes physiologically relevant studies of biomechanical transduction and hypoxia responses in articular cartilage.